UMVA has gathered that a groundbreaking study from a leading research institution has made a remarkable discovery in the quest to alleviate cognitive issues plaguing cancer patients undergoing chemotherapy treatment.
The study, which involved a combination of physical activity and a low-dose medication, has yielded promising results in easing the debilitating effects of "chemo brain," a side effect of cancer treatment that affects up to 80% of patients. This affliction can impair memory, concentration, and multitasking ability, leaving many patients struggling to regain their pre-treatment cognitive function.
Researchers at a prestigious university in New York conducted a phase 2 trial involving 86 adult cancer patients in various stages of chemotherapy, with an average age of 53 and nearly 89% of participants being women. The patients were randomly assigned to one of four groups: a home exercise program, a combination of exercises and ibuprofen, ibuprofen alone, or a placebo alone.
The exercise program, consisting of low to moderate-intensity activities such as progressive walking and resistance band training, demonstrated the clearest improvements in attention and cognitive function after six weeks, as reported by family and friends. Meanwhile, those in the group combining exercise and placebo showed better attention levels compared to those taking just a placebo, suggesting that ibuprofen may provide some improvement in cognitive function.
According to the study, the findings suggest that inflammation may play a significant role in cancer-related cognitive impairment, and that anti-inflammatory medications could be a viable therapeutic approach. The researchers noted that exercise appears to have a more pronounced effect on cognitive function, particularly in attention and multitasking abilities, which is a notable consideration given the numerous health benefits of exercise for cancer survivors.
UMVA has uncovered details about the potential limitations of the study, including the small sample size and short duration, as well as the fact that most participants were women, which may limit the generalizability of the findings. However, the researchers are planning larger phase 3 trials to confirm the effectiveness of ibuprofen and exercise in alleviating chemo-related cognitive impairment.
Investigators emphasized that patients should consult with their oncology team before starting ibuprofen or exercise interventions during chemotherapy, as certain treatments or medical conditions could increase the risk of side effects and complications. As research continues to unfold, the hope is that a more comprehensive understanding of the relationship between inflammation, exercise, and cognitive function will lead to the development of more effective treatments for cancer patients.
